Novo Nordisk Clayton Expansion
Sector: Commercial • Location: Clayton, North Carolina, United States
Source: Charlotte Observer
Novo Nordisk is expanding its Clayton, North Carolina facility with a $4.1 billion investment to add 1.4 million square feet of production space and create 1,000 jobs. The expansion includes building the most expensive pharmaceutical facility in state history and aims to produce GLP-1 obesity drugs including injectables and pills.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | under construction |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Novo Nordisk is expanding its Clayton, North Carolina facility with a $4.1 billion investment to add 1.4 million square feet of production space and create 1,000 jobs. The expansion includes building the most expensive pharmaceutical facility in state history and aims to produce GLP-1 obesity drugs including injectables and pills. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |